Clinical Trials in Austin

Showing 7801-7820 of 15,205 trials

Evaluation of Safety, Tolerability, Pharmacokinetics, Drug-Drug and Food Interactions of Single and Multiple Doses of S-648414 in Healthy Adults

NCT04147715

The primary objective of Part 1 of the study is to evaluate the safety and tolerability of S-648414 after administration of a single oral dose of S-648414 in healthy adult study participants. The primary objective of Part 2 is to evaluate the safety and tolerability of S-648414 after administration of multiple oral doses of S-648414 in healthy adult study participants. The primary objectives of Part 3 are evaluate the safety and tolerability of S-648414 after administration of multiple oral doses of S-648414 in healthy adult study participants, and to evaluate the effect of S-648414 on the pharmacokinetics (PK) of dolutegravir and the effect of dolutegravir on the PK of S-648414 in healthy adult study participants.

Healthy Volunteer

Shionogi98 participantsStarted Oct 2019

Austin, Texas, United States • Hachiōji, Toyko, Japan

COMPLETEDPhase 374 miles

Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)

NCT00329030

This study is designed as a Phase III, multicenter trial, comparing progression-free survival (PFS) after autologous hematopoietic stem cell transplantation using a standard Rituxan plus BEAM transplant regimen versus a regimen adding Bexxar to BEAM.

Lymphoma, B-CellLymphoma, Large-Cell, ImmunoblasticLymphoma, Non-Hodgkin

National Heart, Lung, and Blood Institute (NHLBI)224 participantsStarted Dec 2005

New Haven, Connecticut, United States • Gainesville, Florida, United States • Miami, Florida, United States +33 more locations

Evaluation of Safety, Tolerability, Pharmacokinetics, Drug-Drug and Food Interactions of Single and Multiple Doses of S-648414 in Healthy Adults

Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)

Find Trials by Condition in Austin

Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy

Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403)

Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)

Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age

An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

A Study of HIV-Disease Development in Aging

Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems

Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV

Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants

Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy

Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat

Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV

Adding New Drugs for HIV Infected Patients Failing Current Therapy